Sales of Comfy brand surpass expectations
–Expect steady 3Q23 despite macro uncertainty
3Q NPAT boosted by net fair value gains; expect resilient full-year NBV upswing
China Pharmaceutical & Healthcare: Expecting global funding recovery in the coming quarters
Expect Shengyi to enter Nvidia supply chain in 2024
2Q loss reduction trend better than expectation
Apple FY1Q23 miss on macro and supply chain issues; Expect weakness to persist in near term
Expect $3.5bn CB dilutive effect to be short-term
China Property Sector: NBS Aug data in-line, expect better recovery in SepOct but sustainability is uncertain
Turnaround is here but weaker than expected